Beranda › Sindrom Mielodisplastik
Uji klinis Sindrom Mielodisplastik yang merekrut di AS
157 studi untuk Sindrom Mielodisplastik merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX43 studi
- Baldwin Park, CA26 studi
- New York City, NY21 studi
- Seattle, WA21 studi
- Washington, DC20 studi
- Boston, MA19 studi
- Tampa, FL19 studi
- Miami, FL17 studi
- Columbus, OH14 studi
- Durham, NC14 studi
- Chicago, IL13 studi
- Atlanta, GA13 studi
- St. Louis, MO13 studi
- Cleveland, OH11 studi
- Nashville, TN11 studi
- Philadelphia, PA10 studi
- Birmingham, AL10 studi
- Los Angeles, CA10 studi
- Mountain View, CA9 studi
- Pittsburgh, PA9 studi
- Baltimore, MD9 studi
- Winston-Salem, NC9 studi
- Jacksonville, FL9 studi
- The Bronx, NY9 studi
- Portland, OR8 studi
- Buffalo, NY8 studi
- New Haven, CT8 studi
- Milwaukee, WI8 studi
- Minneapolis, MN8 studi
- Salt Lake City, UT8 studi
- Memphis, TN7 studi
- Clifton, NJ7 studi
- Cedar Rapids, IA7 studi
- Edison, NJ7 studi
- Orange, CA7 studi
- Kansas City, MO7 studi
- San Francisco, CA6 studi
- Aurora, CO6 studi
- Rochester, NY6 studi
- Queens, NY6 studi
Berdasarkan negara bagian
- Alabama10 studi
- Arizona9 studi
- Arkansas4 studi
- California41 studi
- Colorado8 studi
- Connecticut10 studi
- Distrik Columbia4 studi
- Florida31 studi
- Georgia15 studi
- Hawaii3 studi
- Idaho4 studi
- Illinois16 studi
- Indiana4 studi
- Iowa7 studi
- Kansas5 studi
- Kentucky5 studi
- Louisiana5 studi
- Maine4 studi
- Maryland23 studi
- Massachusetts21 studi
- Michigan8 studi
- Minnesota13 studi
- Mississippi3 studi
- Missouri15 studi
- Montana3 studi
- Nebraska4 studi
- Nevada3 studi
- New Hampshire5 studi
- New Jersey13 studi
- New Mexico4 studi
- New York38 studi
- North Carolina19 studi
- North Dakota4 studi
- Ohio22 studi
- Oklahoma4 studi
- Oregon10 studi
- Pennsylvania17 studi
- Rhode Island4 studi
- South Carolina7 studi
- Tennessee15 studi
- Texas44 studi
- Utah8 studi
- Vermont3 studi
- Virginia8 studi
- Washington21 studi
- West Virginia4 studi
- Wisconsin11 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Menerima pesertaFase 1/2
Usia 12 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06303193Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06577441Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06904066Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Menerima pesertaStudi observasional
1 Day – 99 Years · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07683104Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06484062Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
Menerima pesertaFase 1/2
Usia 4 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT03173937The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Menerima pesertaFase 1
Usia 12 hingga 78 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT03802695CHIP/CCUS Natural History Protocol
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04102423MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05564390A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06548230Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT03661307Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05320198Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Menerima pesertaFase 2
Usia 4 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT01174108Natural History Study of GATA2 Deficiency and Related Disorders
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT01905826A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07422480Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Menerima pesertaFase 1
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT03630991CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04375631Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04282187Collection of Tissue Samples for Cancer Research
Menerima pesertaStudi observasional
2 Months · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT00900198Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06904482Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT03471260Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT03683433A Study of BGB-11417 in Participants With Myeloid Malignancies
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT04771130Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.